SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-181823
Filing Date
2014-05-05
Accepted
2014-05-05 12:40:38
Documents
3
Period of Report
2014-05-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d721175d8k.htm 8-K 39177
2 EX-10.1 d721175dex101.htm EX-10.1 111948
3 EX-10.2 d721175dex102.htm EX-10.2 38500
  Complete submission text file 0001193125-14-181823.txt   190912
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 14812355
SIC: 2836 Biological Products, (No Diagnostic Substances)